Skip to main content

AMKOR TECHNOLOGY, INC.

For the period ended Dec 31, 2025. Filed Feb 20, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 20, 2026

AMKR$35.00+6.6%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 16. Form 10-K Summary

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this Annual Report on Form 10-K to be signed, on its behalf by the undersigned, thereunto duly authorized.

By:/s/ Kevin K. Engel
Kevin K. EngelPresident and Chief Executive Officer
Date:February 20, 2026

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Kevin K. Engel and Megan Faust, and each of them, his or her attorneys-in-fact, and agents, each with the power of substitution, for and in the name, place and stead of such person, in any and all capacities, to sign any and all amendments to this Form 10-K, and all documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and conforming all that said attorneys-in-fact and agents of any of them, or his, her or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Form 10-K has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

NameTitleDate
/s/ Kevin K. EngelPresident and Chief Executive OfficerFebruary 20, 2026
Kevin K. Engel(Principal Executive Officer)
/s/ Megan FaustExecutive Vice President, Chief Financial Officer, and TreasurerFebruary 20, 2026
Megan Faust(Principal Financial Officer)
/s/ Cherie BuntynSenior Vice President and Chief Accounting OfficerFebruary 20, 2026
Cherie Buntyn(Principal Accounting Officer)
/s/ Susan Y. KimChairmanFebruary 20, 2026
Susan Y. Kim
/s/ Douglas A. AlexanderDirectorFebruary 20, 2026
Douglas A. Alexander
/s/ Roger A. CarolinDirectorFebruary 20, 2026
Roger A. Carolin
NameTitleDate
/s/ Winston J. ChurchillDirectorFebruary 20, 2026
Winston J. Churchill
/s/ Daniel LiaoDirectorFebruary 20, 2026
Daniel Liao
/s/ MaryFrances McCourtDirectorFebruary 20, 2026
MaryFrances McCourt
/s/ Robert R. MorseDirectorFebruary 20, 2026
Robert R. Morse
/s/ Giel Marie Jean RuttenDirectorFebruary 20, 2026
Giel Marie Jean Rutten
/s/ Gil C. TilyDirectorFebruary 20, 2026
Gil C. Tily
/s/ David N. WatsonDirectorFebruary 20, 2026
David N. Watson
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.